The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation

Prostate cancer is the most commonly diagnosed cancer, with an estimated 240,000 new cases reported annually in the United States. Due to early detection and advances in therapies, more than 90% of patients will survive 10 years post diagnosis and treatment. Radiation is a treatment option often use...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberley-Deegan, Rebecca E., Steffan, Joshua J., Rove, Kyle O., Pate, Kathryn M., Weaver, Michael W., Spasojevic, Ivan, Frederick, Barbara, Raben, David, Meacham, Randall B., Crapo, James D., Koul, Hari K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440381/
https://www.ncbi.nlm.nih.gov/pubmed/22984473
http://dx.doi.org/10.1371/journal.pone.0044178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440381/
https://www.ncbi.nlm.nih.gov/pubmed/22984473
http://dx.doi.org/10.1371/journal.pone.0044178

Ejemplares similares